Nurses say hospitals aren’t prepared for COVID-19 surge during flu season
Nurses say hospitals aren't preparing for another surge in COVID-19 cases and still lack adequate personal protective equipment. More
Blog
Despite ACA Coverage Gains, Millions Still Suffer ‘Catastrophic’ Health Care Costs
The president-elect has vowed to strengthen the Affordable Care Act, which gave millions of Americans health insurance. But many insured people still struggle to pay for health care, research finds. More
Create a scorecard to help make safety-net providers accountable to patients and the public
State and national scorecards grade health care providers' work. No scorecard exists for safety-net providers caring for Medicaid patients. More
Here’s how Michigan health care experts are reducing risks of medication overload
A Lown Institute study found 750 older Americans are hospitalized daily due to serious medication side effects. With each additional drug taken, risks of serious reactions increase 7-10%. More than 40% of older Americans take five or more prescription drugs. Nearly 20% take more than 10. Add in over-the-counter medications, and that number rises to 66%. More
Mass. Plan Swaps Hospital Competition For Collaboration As COVID-19 Surges A Second Time
Hospitals, grouped into five areas, will meet at least weekly to share updates about their bed capacity, staffing levels, PPE and other supplies, and ability to accept transfer patients. More
How A Minneapolis Clinic Is Narrowing Racial Gaps In Health
For five decades, NorthPoint Health & Wellness Center has confronted the ways disparities can hurt its patients' health. Community leaders say it's a model for cities facing similar struggles. More
Five Important Questions About Pfizer’s COVID-19 Vaccine
The drugmaker says its mRNA vaccine worked in 90% of patients in its trial, but some observers question how long immunity will last and who will benefit. More
Relationships Between Academic Medicine Leaders and Industry—Time for Another Look?
In 2017, 12 of the 19 largest pharmaceutical and biotech companies in the world reportedly had at least 1 member of the board of directors who also served a leadership role at a nonprofit AMC. More
Video: Measuring patient satisfaction in hospitals
How can we measure the ways in which hospital environments promote healing? And what do we find on the Lown Index when it comes to patient satisfaction? Shannon Brownlee and Dr. Vikas Saini tackle these questions and more in this week's video. More
Debunking popular Covid-19 myths
Misinformation about Covid-19 spreads as quickly as the virus, through social media and even from government officials. Let's examine some popular myths about Covid-19 and see if there is any truth to these claims. More
Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018
This economic evaluation study estimates the number of patients with cancer who are eligible for the newly approved drug-indication pairs and projects potential spending and use of the approvals in the United States. More
Health experts want to prioritize people of color for a Covid-19 vaccine. But how should it be done?
Public health experts support giving preference for a Covid-19 vaccine to communities that have experienced high rates of illness. More
Inappropriately prescribed antibiotics will likely accompany the winter surge of Covid-19
Antibiotics were overprescribed long before Covid-19 emerged. The pandemic may lead to a surge in antibiotic use, much of it inappropriate. More
Hit hardest by COVID-19, Alaska’s Pacific Islanders face death and severe illness at an alarming rate
They are nearly 30 times more likely to be hospitalized and 12 times more likely to die from COVID-19 as Alaska’s white population, according to state data. More
Defending the honor of our healthcare colleagues
We are facing a tragic, threatening surge of COVID-19 cases across large parts of the nation, in the midst of a divisive election. A global pandemic is tragedy enough for any nation, but in the U.S. it has also become a political flashpoint. More
I was a ‘nonadherent’ patient. That’s made me a more empathetic doctor
I once stopped taking some of the pills I needed to fight non-Hodgkin's lymphoma. That has helped me understand my "nonadherent" patients. More
Hospices help communities grieve during COVID-19
Hospices are serving as a resource for their communities as they use their experience in grief and bereavement counseling to help local residents connect and work through their struggles. More
Residents say they – and Medicare – were duped by community COVID, antibody testing
Some Palm Beach County communities are questioning extra and unnecessary testing done - and billed to Medicare - for COVID. More
F.D.A. Panel Declines to Endorse Controversial Alzheimer’s Drug
The drug, aducanumab, made by Biogen, would be the first new Alzheimer’s treatment in nearly two decades. But the advisory panel said there was not enough evidence of its effectiveness in slowing cognitive decline. More
The “deimplementation” process: Stopping overuse in pediatric care
Overuse in pediatrics is prevalent, but often goes overlooked. How can we improve health care value for people of all ages? Researchers argue that it is time for the field of pediatrics to develop their own pediatric "deimplementation science" to improve children's health. More